Yao Q, Zhang X, Wang Y, Wang C, Chen J, Chen D
Eur J Med Res. 2024; 29(1):73.
PMID: 38268058
PMC: 10807100.
DOI: 10.1186/s40001-024-01659-0.
Duault C, Kumar A, Taghi Khani A, Lee S, Yang L, Huang M
Blood. 2021; 138(16):1465-1480.
PMID: 34077953
PMC: 8532198.
DOI: 10.1182/blood.2020009871.
Hu W, Wang G, Huang D, Sui M, Xu Y
Front Immunol. 2019; 10:1205.
PMID: 31214177
PMC: 6554437.
DOI: 10.3389/fimmu.2019.01205.
Ravindranath M, Filippone E, Devarajan A, Asgharzadeh S
Monoclon Antib Immunodiagn Immunother. 2019; 38(2):38-59.
PMID: 31009335
PMC: 6634170.
DOI: 10.1089/mab.2018.0043.
Vargas-Inchaustegui D, Hait S, Chung H, Narola J, Hoang T, Robert-Guroff M
J Immunol. 2017; 199(9):3202-3211.
PMID: 28947538
PMC: 5679748.
DOI: 10.4049/jimmunol.1700586.
Evaluation of Functional NK Cell Responses in Vaccinated and SIV-Infected Rhesus Macaques.
Vargas-Inchaustegui D, Ying O, Demberg T, Robert-Guroff M
Front Immunol. 2016; 7:340.
PMID: 27630641
PMC: 5005425.
DOI: 10.3389/fimmu.2016.00340.
Generation of CD2(+)CD8(+) NK Cells from c-kit(+) Bone Marrow Cells in Porcine.
Lim K, Han J, Roh Y, Kim B, Kwon J, You M
Korean J Physiol Pharmacol. 2012; 16(3):167-74.
PMID: 22802697
PMC: 3394918.
DOI: 10.4196/kjpp.2012.16.3.167.
Mouse NK cell-mediated rejection of bone marrow allografts exhibits patterns consistent with Ly49 subset licensing.
Sun K, Alvarez M, Ames E, Barao I, Chen M, Longo D
Blood. 2011; 119(6):1590-8.
PMID: 22184406
PMC: 3286220.
DOI: 10.1182/blood-2011-08-374314.
Natural killer-cell differentiation by myeloid progenitors.
Grzywacz B, Kataria N, Kataria N, Blazar B, Miller J, Verneris M
Blood. 2010; 117(13):3548-58.
PMID: 21173117
PMC: 3072878.
DOI: 10.1182/blood-2010-04-281394.
NK-dependent increases in CCL22 secretion selectively recruits regulatory T cells to the tumor microenvironment.
Mailloux A, Young M
J Immunol. 2009; 182(5):2753-65.
PMID: 19234170
PMC: 3337694.
DOI: 10.4049/jimmunol.0801124.
Immunization of Rhesus monkeys with a SialylTn-mAb17-1A conjugate vaccine co-formulated with QS-21 induces a temporary systemic cytokine release and NK cytotoxicity against tumor cells.
Kircheis R, Siegl P, Grunt S, Halanek N, Loibner H, Mudde G
Cancer Immunol Immunother. 2006; 56(6):863-73.
PMID: 17009044
PMC: 11030659.
DOI: 10.1007/s00262-006-0231-x.
Flow cytometry--a rapid tool to correlate functional activities of human peripheral blood lymphocytes with their corresponding phenotypes after in vitro stimulation.
Nirmala R, Narayanan P
BMC Immunol. 2002; 3:9.
PMID: 12165101
PMC: 122086.
DOI: 10.1186/1471-2172-3-9.
The role of cytotoxic T-lymphocytes in the prevention and immune surveillance of tumors--lessons from normal and immunodeficient mice.
Svane I, Boesen M, ENGEL A
Med Oncol. 2000; 16(4):223-38.
PMID: 10618685
DOI: 10.1007/BF02785868.
Reversal of human immunodeficiency virus type 1 protein-induced inhibition of natural killer cell activity by alpha interferon and interleukin-2.
Nair M, Schwartz S
Clin Diagn Lab Immunol. 2000; 7(1):101-5.
PMID: 10618286
PMC: 95831.
DOI: 10.1128/CDLI.7.1.101-105.2000.
T helper 1 (Th1) and Th2 characteristics start to develop during T cell priming and are associated with an immediate ability to induce immunoglobulin class switching.
Toellner K, Luther S, Sze D, Choy R, Taylor D, MacLennan I
J Exp Med. 1998; 187(8):1193-204.
PMID: 9547331
PMC: 2212236.
DOI: 10.1084/jem.187.8.1193.
Predictors of survival in human immunodeficiency virus type 1-seropositive intravenous drug users.
Page J, Lai S, Fletcher M, Patarca R, Smith P, Lai H
Clin Diagn Lab Immunol. 1996; 3(1):51-60.
PMID: 8770504
PMC: 170247.
DOI: 10.1128/cdli.3.1.51-60.1996.
Characterization of unique lymphoid cells derived from murine spleen which constitutively produce interleukin-6.
ONeill H, Ni K
Immunology. 1993; 79(2):220-8.
PMID: 8344701
PMC: 1421868.
Interferon beta enhances the natural killer activity of patients with bladder carcinoma.
Molto L, Carballido J, Manzano L, Olivier C, Lapena P, Alvarez-Mon M
Cancer Immunol Immunother. 1994; 38(6):406-10.
PMID: 8205562
PMC: 11038773.
DOI: 10.1007/BF01517211.
BY55 monoclonal antibody delineates within human cord blood and bone marrow lymphocytes distinct cell subsets mediating cytotoxic activity.
Bensussan A, Gluckman E, el Marsafy S, Schiavon V, Mansur I, Dausset J
Proc Natl Acad Sci U S A. 1994; 91(19):9136-40.
PMID: 8090781
PMC: 44762.
DOI: 10.1073/pnas.91.19.9136.
NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80.
Cella M, Longo A, Ferrara G, Strominger J, Colonna M
J Exp Med. 1994; 180(4):1235-42.
PMID: 7931060
PMC: 2191670.
DOI: 10.1084/jem.180.4.1235.
